Evaluation of psychometric properties of Japanese version of International Prostate Symptom Score and BPH Impact Index

Japanese Journal of Urology

Volumn 94, Issue 5, 2003, Pages 560-569

  Homma, Yukio ^a   Tsukamoto, Taiji ^a   Yasuda, Kousaku ^a   Ozonor, Seiichiro ^a   Yoshida, Masaki ^a   Yamaguchi, Takuhiro ^a  

^a NONE

Author keywords

Benign prostatic hyperplasia; Symptom score; Validation

Indexed keywords

ADULT; AGED; ARTICLE; BPH IMPACT INDEX; ETHNIC GROUP; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; JAPAN; MAJOR CLINICAL STUDY; MALE; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PSYCHOMETRY; QUALITY OF LIFE; SCORING SYSTEM; SYMPTOMATOLOGY;

EID: 0042532077     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.94.560     Document Type: Article

References (14)

1. Barry, M.J., Fowler, F.J., Jr., O'Leary, M.P., Bruskewitz, R.C., Holtgrewe, H.L., Mebust, W.K. and Cockett, A.T.: The American Urological Association symptom index for benign prostatic hyperplasia. Measurement Committee of The American Urological Association. J. Urol., 148: 1549-1557, 1992.
2. Hald, T., Nordling, J., Andersen, J.T., Bilde, T., Meyhoff, H.H. and Walter, S.A.: Patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand. J. Urol. Nephrol., Suppl, 138: 59-62, 1991.
3. Donovan, J.L., Abrams, P., Peters, T.J., Kay, H.E., Reynard, J., Chapple, C., De La Rosette, J.J. and Kondo, A.: The ICS- 'BPH' Study: the psychometric validity and reliability of the ICS male questionnaire. Br. J. Urol., 77: 554-562, 1996.
4. Recommendations of the 2nd International Consensus Committee. In: Proceedings of the International Consultation on Benign Prostatic Hyperplasia. Edited by A.T. K. Cockett, S. Khoury, Y. Aso, C. Chatelain, L. Denis, K. Griffiths, G. Murphy. Jersey: Scientific Communication International Ltd., p553-672, 1994.
5. Badia, X., Garcia-Losa, M. and Dal-Re, R.: Ten-language translation and harmonization of the International Prostate symptom Score: developing a methodology for multinational clinical trials, Eur. Urol., 31:129-140, 1997.
6. Quek, K.F., Low, W.Y., Razack, A.H. and Loh, C.S.: Reliability and validity of the International Prostate Symptom Score in a Malaysian population. BJU. Int., 88: 21-25, 2001.
7. Barry, M.J., Fowler, F.J., Jr., O'Leary, M.P., Bruskewitz, R.C., Holtgrewe, H.L., Mebust, W.K. and Cockett, A. T.: Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. J. Urol., 148: 1558-1563, 1992.
8. Barry, M.J., Williford, W.O., Chang, Y., Machi, M., Jones, K.M., Waker-Corkery, E. and Lepor, H.: Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J. Urol., 154: 1770-1774, 1995.
9. Barry, M.J., Williford, W.O., Fowler, F.J. Jr., Jones. K.M. and Lepor, H.: Filling and voiding symptoms in the American urological association symptom index: The value of their distinction in a veterans affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia. J. Urol., 164: 1559-1564, 2000.
10. Barry, M.J., Fowler, F.J., Jr., O'Leary, M.P., Bruskewitz, R.C., Holtgrewe, H.L. and Mebust, W.K.: Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association. Med. Care, 33: AS145-155, 1995.
11. Homma, Y., Yamaguchi, T., Kondo, Y., Horie, S., Takahashi, S. and Kitamura, T.: Significance of nocturia for international prostate symptom score in benign prostatic hyperplasia. J. Urol., 167: 172-176, 2002.